Long, Noncoding RNA Dysregulation in Glioblastoma

Area of Science:

• Genomics
• Molecular Biology
• Neuro-oncology

Background:

• Over 70% of the human genome is transcribed, producing functional noncoding RNAs.
• Long, noncoding RNAs (lncRNAs) are key regulators of cellular processes.
• The brain exhibits the highest expression of lncRNAs, implicating them in neurological functions and diseases.

Purpose of the Study:

• To review the general mechanisms and biological roles of lncRNAs.
• To focus on the specific roles of lncRNAs in glioblastoma (GBM).
• To discuss RNA-based therapeutics for GBM.

Main Methods:

• Literature review of lncRNA functions.
• Analysis of lncRNA involvement in GBM pathogenesis.
• Examination of current RNA-based therapeutic strategies.

Main Results:

• lncRNAs are implicated in cellular processes and are vital in health and disease.
• Glioblastoma (GBM) exhibits significant intratumoral heterogeneity, complicating treatment.
• lncRNAs contribute to GBM's rapid adaptation, therapeutic evasion, and recurrence.

Conclusions:

• lncRNAs are critical players in GBM's complexity and treatment resistance.
• Understanding lncRNA roles is essential for developing effective GBM therapies.
• RNA-based therapeutics show promise for treating GBM.